CNS Stock Analysis: Cohen & Steers | NYSE
Asset Management | NYSE, USA | Market Cap: 4.153m USD | 12M Return: 13.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 23.6M
EPS Trend: 85.5%
Qual. Beats: 0
Rev. Trend: 96.6%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cohen & Steers, Inc. (NYSE: CNS) is a publicly traded asset management holding company founded in 1986 and headquartered in New York. The firm provides investment management services to institutional investors such as pension funds, endowments, and foundations, offering equity, fixed income, multi-asset, and commodity portfolios, as well as mutual funds and hedge funds launched through its subsidiaries.
The company specializes in real assets and alternative income, with a focus on real estate (including REITs), infrastructure, natural resource equities, commodities, and preferred securities. Its sector focus and product lineup in real assets differentiate it from broader diversified asset managers, and as a publicly listed asset manager (GICS: Asset Management & Custody Banks), its revenue is primarily driven by fees calculated on assets under management (AUM).
- REIT sector performance drives AUM and fee revenue
- Rising rates pressure preferred security and real estate valuations
- Net asset flows reflect demand for real asset strategies
| Net Income: 168.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 1.56 > 1.0 |
| NWC/Revenue: 21.25% < 20% (prev 48.76%; Δ -27.50% < -1%) |
| CFO/TA -0.01 > 3% & CFO -7.92m > Net Income 168.3m |
| Net Debt (83.2m) to EBITDA (218.3m): 0.38 < 3 |
| Current Ratio: 9.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (51.6m) vs 12m ago 0.34% < -2% |
| Gross Margin: 76.60% > 18% (prev 49.54%; Δ 27.07% > 0.5%) |
| Asset Turnover: 70.92% > 50% (prev 67.75%; Δ 3.16% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.15 (Total Current Assets 141.7m - Total Current Liabilities 14.4m) / Total Assets 854.7m |
| B: -0.12 (Retained Earnings -98.9m / Total Assets 854.7m) |
| C: 0.25 (EBIT TTM 207.3m / Avg Total Assets 844.8m) |
| D: 3.00 (Book Value of Equity 563.4m / Total Liabilities 187.8m) |
| Altman-Z'' = 5.40 = AAA |
| DSRI: 1.04 (Receivables 91.2m/82.9m, Revenue 599.1m/565.6m) |
| GMI: 0.65 (GM 49.54% / 76.60%) |
| AQI: 1.45 (AQ_t 0.65 / AQ_t-1 0.45) |
| SGI: 1.06 (Revenue 599.1m / 565.6m) |
| TATA: 0.21 (NI 168.3m - CFO -7.92m) / TA 854.7m) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of July 28, 2026, the stock is trading at USD 81.06 with a total of 194,153 shares traded. Over the past week, the price has changed by -1.75%, over one month by +7.56%, over three months by +20.05% and over the past year by +13.19%.
Current recommended Stop Loss: 76.70 (which is 5.4% or 1.5 ATR below the current price).
Cohen & Steers has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CNS.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 71.3 | -12% |
P/E Trailing = 25.0308
P/E Forward = 22.4719
P/S = 6.6658
P/B = 7.2982
P/EG = 2.0059
Revenue TTM = 599.1m USD
EBIT TTM = 207.3m USD
EBITDA TTM = 218.3m USD
Long Term Debt = unknown (none)
Short Term Debt = 15.4m USD (from shortTermDebt, last fiscal year)
Debt = 136.3m USD (from shortLongTermDebtTotal, last quarter) (leases 136.3m already included)
Net Debt = 83.2m USD (calculated: Debt 136.3m - CCE 53.1m)
Enterprise Value = 4.24b USD (4.15b + Debt 136.3m - CCE 53.1m)
Interest Coverage Ratio = unknown (Ebit TTM 207.3m / Interest Expense TTM 0.0)
EV/FCF = -330.4x (Enterprise Value 4.24b / FCF TTM -12.8m)
FCF Yield = -0.30% (FCF TTM -12.8m / Enterprise Value 4.24b)
FCF Margin = -2.14% (FCF TTM -12.8m / Revenue TTM 599.1m)
Net Margin = 28.09% (Net Income TTM 168.3m / Revenue TTM 599.1m)
Gross Margin = 76.60% ((Revenue TTM 599.1m - Cost of Revenue TTM 140.2m) / Revenue TTM)
Gross Margin QoQ = 88.32% (prev 85.35%)
Tobins Q-Ratio = 4.96 (Enterprise Value 4.24b / Total Assets 854.7m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 136.3m)
Taxrate = 25.52% (57.9m / 227.1m)
NOPAT = 154.4m (EBIT 207.3m * (1 - 25.52%))
Current Ratio = 9.86 (Total Current Assets 141.7m / Total Current Liabilities 14.4m)
Debt / Equity = 0.24 (Debt 136.3m / totalStockholderEquity, last quarter 563.4m)
Debt / EBITDA = 0.38 (Net Debt 83.2m / EBITDA 218.3m)
Debt / FCF = -6.49 (negative FCF - burning cash) (Net Debt 83.2m / FCF TTM -12.8m)
Total Stockholder Equity = 551.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 19.92% (Net Income 168.3m / Total Assets 854.7m)
RoE = 30.54% (Net Income TTM 168.3m / Total Stockholder Equity 551.0m)
RoCE = 24.67% (EBIT 207.3m / Capital Employed (Total Assets 854.7m - Current Liab 14.4m))
RoIC = 18.70% (NOPAT 154.4m / Invested Capital 825.8m)
WACC = 8.81% (E(4.15b)/V(4.29b) * Re(9.10%) + D(136.3m)/V(4.29b) * Rd(0.0%) * (1-Tc(0.26)))
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 89.71 | Cagr: 1.76%
[DCF] Fair Price = unknown (Cash Flow -12.8m)
EPS Correlation: 85.45 | EPS CAGR: 5.17% | SUE: 0.72 | # QB: 0
Revenue Correlation: 96.59 | Revenue CAGR: 7.42% | SUE: 2.67 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.93 | Chg30d=+1.09% | Revisions=+40% | Analysts=1
EPS current Year (2026-12-31): EPS=3.52 | Chg30d=+2.82% | Revisions=+25% | GrowthEPS=+13.9% | GrowthRev=+9.9%
EPS next Year (2027-12-31): EPS=3.87 | Chg30d=+1.31% | Revisions=+25% | GrowthEPS=+10.0% | GrowthRev=+8.9%
[Analyst] Revisions Ratio: +57% (up=4, down=0)